{"schema_version":1,"assessment_id":"eoa_inverse_innovation_exp03_opportunity320_20260801","source_experiment_id":"eoa_inverse_innovation_exp03_full320_20260801","cell_id":"negative_space_design__medicine_healthcare","archetype_slug":"negative_space_design","domain_slug":"medicine_healthcare","title":"Reversible negative-space focus for time-critical EHR review","opportunity_summary":"A reversible EHR review mode would demote verified secondary content and protect space around current critical changes while retaining labels, immediate reveal-all recovery, and urgency-triggered restoration. Its proposed advantage over additive salience is reduced perceptual competition, but effectiveness, classification reliability, demand, prevalence, and distinctiveness remain unverified hypotheses.","adopter_authorizer":"A hospital clinical-informatics authority, jointly gated by patient-safety, nursing, pharmacy, accessibility, relevant clinical-service leadership, and EHR implementation stakeholders; individual clinicians retain treatment authority.","scores":{"meaningful_impact":{"score":4,"rationale":"If present critical information is being buried by display competition, faster and more reliable recognition could materially improve patient safety and clinician review efficiency. The packet supplies no prevalence or realized-impact evidence, preventing a top score."},"stakeholder_pull":{"score":3,"rationale":"Clinicians, patients, informatics, nursing, pharmacy, accessibility, and safety teams have plausible interests in reducing missed findings, but the sealed candidate contains no interviews, procurement signals, adoption requests, or measured demand."},"incremental_advantage":{"score":3,"rationale":"The proposal makes a testable incremental claim against both the dense baseline and an additive color/icon/bolding rival by protecting absence and recoverability. Whether this improves detection without harming context comprehension is unknown."},"distinctiveness_plausibility":{"score":2,"rationale":"The protected-space, explicit empty-state, reveal-all, and restoration bundle is specifically described, but the packet identifies possible overlap with focus views, progressive disclosure, hierarchy redesign, and alert management, and prior art is unsearched."},"technical_implementability":{"score":3,"rationale":"A synthetic-case prototype appears technically feasible, but safe production use depends on reliable task-specific criticality classification, responsive and assistive layouts, discoverable recovery, and EHR integration."},"adoption_authority_feasibility":{"score":3,"rationale":"The authorizing institution and required clinical and safety gates are identifiable, but approval requires coordination across several authorities and evidence that concealment rules do not impair care or accessibility."},"evidence_readiness":{"score":4,"rationale":"The packet specifies a bounded randomized synthetic-case comparison, concrete benefit and harm outcomes, distinct problem and intervention falsifiers, exclusions, and halt criteria. Study materials, classification rules, and validated cases still must be developed."},"safety_net_benefit":{"score":3,"rationale":"The intervention could help time-pressured clinicians and explicitly includes accessibility and equity objectives, but no evidence establishes benefit in resource-constrained settings or protection of any particular underserved group."},"scalability":{"score":2,"rationale":"The mechanism could in principle recur across review screens, but patient-, task-, service-, device-, accessibility-, and workflow-specific classification requirements create substantial localization, governance, and monitoring burdens."}},"score_confidence":"MODERATE","costs":{"first_evidence":{"band_2026_usd":"50K_TO_250K","scope":"Design and run one bounded randomized usability study using synthetic cases, representative clinicians, a baseline, an additive-salience rival, and a reversible negative-space prototype.","confidence":"MODERATE","assumptions":["No live records or clinical decisions are involved.","Costs include prototype design, synthetic-case adjudication, clinician recruitment, accessibility participation, analysis, governance review, and study coordination.","The prototype is not production-grade or integrated with a live EHR."]},"initial_deployment_startup":{"band_2026_usd":"1M_TO_5M","scope":"Develop and validate a production-grade implementation for a bounded set of review tasks at one health system, including integration, classification rules, accessibility, security, compliance, monitoring, and rollback.","confidence":"LOW","assumptions":["A willing health-system and EHR integration partner are available.","Deployment remains limited to selected workflows rather than the whole EHR.","Substantial human adjudication and safety validation are required before activation.","Vendor licensing and integration constraints are unknown."]},"operational_launch":{"band_2026_usd":"1M_TO_5M","scope":"Launch across multiple services within one health system with training, workflow configuration, phased activation, safety surveillance, accessibility validation, support, and evaluation.","confidence":"LOW","assumptions":["Initial deployment evidence satisfies institutional safety gates.","Clinical services require separate configuration and acceptance testing.","Launch includes comparison against the existing interface and rapid rollback capability.","No nationwide or multi-vendor rollout is included."]},"annual_recurring":{"band_2026_usd":"250K_TO_1M","scope":"Maintain classification rules, integrations, accessibility behavior, monitoring, incident review, user support, retraining, and governance for a bounded health-system deployment.","confidence":"LOW","assumptions":["The implementation covers several clinical services at one health system.","EHR and workflow changes require recurring regression testing.","Human safety oversight remains necessary.","Major vendor license changes or redevelopment are excluded."]}},"research_burden":"HIGH","earliest_credible_horizon":"3_TO_12_MONTHS","pipeline_gates":{"recognizable_externally_supportable_problem":{"status":"UNCERTAIN","reason":"The packet clearly specifies present critical information competing with dense visible content, but supplies no external observation, prevalence evidence, or measured association with recognition failures."},"identifiable_adopter_or_authorizer":{"status":"YES","reason":"The candidate identifies the hospital clinical-informatics authority and joint patient-safety, nursing, pharmacy, accessibility, and clinical-service gates while reserving treatment authority to clinicians."},"distinct_testable_incremental_claim":{"status":"YES","reason":"The protected-absence prototype can be compared directly with both the dense baseline and an additive-salience rival on detection, misses, action time, context comprehension, recovery behavior, and subgroup harms."},"bounded_next_evidence_step":{"status":"YES","reason":"A randomized study with representative clinicians, adjudicated synthetic cases, no live-record connection, explicit comparisons, falsifiers, and halt criteria is bounded and decision-relevant."},"no_unresolved_safety_or_authority_stop":{"status":"YES","reason":"For the authorized first study, synthetic data, prohibited concealment targets, immediate recovery, clinician authority, miss-triggered halting, and baseline rollback address the identified safety and authority stops. This does not authorize clinical deployment."},"implementation_cost_scope_and_range":{"status":"UNCERTAIN","reason":"The synthetic study is scoped, but production breadth, EHR architecture, vendor participation, classification-maintenance workload, compliance requirements, and service-specific configuration are not established, so implementation ranges remain low-confidence resource bands."}},"blocking_evidence":["No external evidence establishes that display competition materially affects recognition time or miss rate when necessary information is present.","The reliability of classifying content as critical, necessary context, or safely demotable has not been demonstrated.","It is unknown whether the prototype outperforms additive salience without reducing context comprehension or dense-comparison efficiency.","Accessibility subgroup performance, small-screen behavior, assistive-technology behavior, and recovery discoverability are untested.","Stakeholder demand, workflow fit, governance acceptance, and vendor integration feasibility are unverified.","Prior-art distinctiveness from focus views, progressive disclosure, hierarchy redesign, and alert-management approaches is unverified."],"next_evidence_step":"Predefine and independently adjudicate criticality and demotion rules, then run the authorized randomized synthetic-case study comparing the dense baseline, additive-salience rival, and reversible negative-space prototype. Measure critical-item miss rate, recognition and action time, context comprehension, classification-caused concealment, reveal-all recovery, dense-comparison performance, and accessibility subgroup outcomes; falsify advancement if the prototype provides no meaningful benefit over both comparators or increases any safety-critical miss or material subgroup harm.","research_questions":["Does visible competition predict recognition time or miss rate after task complexity, expertise, and information accuracy are controlled?","Can independent clinical adjudicators classify critical, contextual, and demotable content with sufficient agreement and acceptably low concealment error?","Does protected absence outperform additive salience on detection while preserving context comprehension and expert comparison efficiency?","How often do users invoke reveal-all, and can all users promptly find and operate recovery controls?","Do responsive layouts and assistive technologies preserve spacing, labels, reading order, and safety-critical controls?","Which clinical tasks benefit, and which require continuously dense side-by-side evidence?","Will the identified institutional authorities and EHR stakeholders sponsor a bounded evaluation and define acceptable advancement thresholds?","Which elements, if any, are distinct from existing focus views, progressive disclosure, hierarchy redesign, or alert-management implementations?"] ,"recommendation":"PARTNERED_RESEARCH","uncertainty_constraints":["Closed-book assessment: no external prevalence, market, effectiveness, adoption, or cost evidence was available.","Benefit depends on the problem being perceptual competition rather than missing data, interruptions, staffing pressure, or workflow failure.","Production feasibility depends on task-specific criticality classification that may vary by patient, clinician, service, and moment.","Safety claims apply only to the synthetic first study and do not establish readiness for live clinical use.","Cost bands are resource-equivalent planning ranges, not vendor quotations or point estimates.","Scalability and safety may differ materially across EHRs, devices, responsive layouts, and accessibility technologies."],"closed_book_prior_art_boundary":"Prior art was not searched and remains unverified. No claim is made about novelty, prevalence, existing implementations, market differentiation, or freedom to operate; distinctiveness must be established through external prior-art research."}